Aviva PLC reduced its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 44.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 299,314 shares of the company's stock after selling 242,680 shares during the period. Aviva PLC owned about 0.06% of Nutrien worth $13,366,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in NTR. Covea Finance increased its position in shares of Nutrien by 21.9% during the fourth quarter. Covea Finance now owns 55,600 shares of the company's stock worth $2,485,000 after acquiring an additional 10,000 shares during the period. Wellington Management Group LLP increased its holdings in Nutrien by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 1,396,887 shares of the company's stock worth $67,200,000 after purchasing an additional 151,596 shares during the period. Charles Schwab Investment Management Inc. raised its position in Nutrien by 8.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,886,376 shares of the company's stock valued at $84,367,000 after purchasing an additional 144,025 shares in the last quarter. Van ECK Associates Corp raised its position in Nutrien by 5.7% in the 4th quarter. Van ECK Associates Corp now owns 1,480,870 shares of the company's stock valued at $66,264,000 after purchasing an additional 80,382 shares in the last quarter. Finally, Secured Retirement Advisors LLC purchased a new position in shares of Nutrien in the 4th quarter valued at about $654,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Stock Performance
NTR traded up $2.73 on Friday, hitting $51.05. 2,557,390 shares of the company traded hands, compared to its average volume of 2,068,506. Nutrien Ltd. has a 12-month low of $43.70 and a 12-month high of $60.87. The company has a 50 day moving average of $50.74 and a 200-day moving average of $49.13. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $24.96 billion, a PE ratio of 37.26, a PEG ratio of 1.19 and a beta of 0.77.
Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The company had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $5.09 billion. Sell-side analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current year.
Nutrien Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Stockholders of record on Monday, March 31st were paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 4.27%. The ex-dividend date of this dividend was Monday, March 31st. Nutrien's dividend payout ratio (DPR) is presently 159.12%.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on NTR shares. Mizuho raised their target price on shares of Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a report on Thursday, February 20th. JPMorgan Chase & Co. raised shares of Nutrien from an "underweight" rating to a "neutral" rating and lifted their price objective for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. Barclays boosted their target price on shares of Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. Scotiabank lifted their price target on Nutrien from $60.00 to $62.00 and gave the stock a "sector outperform" rating in a report on Monday, February 24th. Finally, Wells Fargo & Company upped their price objective on Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $60.00.
Read Our Latest Report on Nutrien
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Stories

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.